Development and Validation of a Risk Nomogram Model for Predicting Recurrence in Patients with Atrial Fibrillation After Radiofrequency Catheter Ablation

References

• Chung MK, Refaat M, Shen WK, et al. Atrial fibrillation: JACC council perspectives. J Am Coll Cardiol. 2020;75(14):1689–1713. doi:10.1016/j.jacc.2020.02.025
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Rillig A, Magnussen C, Ozga AK, et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation. 2021;144(11):845–858. doi:10.1161/CIRCULATIONAHA.121.056323
   PubMed Web of Science ®Google Scholar
• Poole JE, Bahnson TD, Monahan KH, et al. Recurrence of atrial fibrillation after catheter ablation or antiarrhythmic drug therapy in the CABANA trial. J Am Coll Cardiol. 2020;75(25):3105–3118. doi:10.1016/j.jacc.2020.04.065
   PubMed Web of Science ®Google Scholar
• Erhard N, Metzner A, Fink T. Late arrhythmia recurrence after atrial fibrillation ablation: incidence, mechanisms and clinical implications. Herzschrittmacherther Elektrophysiol. 2022;33(1):71–76. doi:10.1007/s00399-021-00836-6
   PubMedGoogle Scholar
• Li Z, Wang S, Hidru TH, et al. Long atrial fibrillation duration and early recurrence are reliable predictors of late recurrence after radiofrequency catheter ablation. Front Cardiovasc Med. 2022;9:864417. doi:10.3389/fcvm.2022.864417
   PubMed Web of Science ®Google Scholar
• Winkle RA, Jarman JW, Mead RH, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016;13(11):2119–2125. doi:10.1016/j.hrthm.2016.07.018
   PubMed Web of Science ®Google Scholar
• Mulder MJ, Kemme M, Hopman L, et al. Comparison of the predictive value of ten risk scores for outcomes of atrial fibrillation patients undergoing radiofrequency pulmonary vein isolation. Int J Cardiol. 2021;344:103–110. doi:10.1016/j.ijcard.2021.09.029
   PubMed Web of Science ®Google Scholar
• Harada M, Nattel S. Implications of inflammation and fibrosis in atrial fibrillation pathophysiology. Card Electrophysiol Clin. 2021;13(1):25–35. doi:10.1016/j.ccep.2020.11.002
   PubMedGoogle Scholar
• Wu N, Xu B, Xiang Y, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol. 2013;169(1):62–72. doi:10.1016/j.ijcard.2013.08.078
   PubMed Web of Science ®Google Scholar
• Chang Y, An H, Xu L, et al. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer. 2015;113(4):626–633. doi:10.1038/bjc.2015.241
   PubMed Web of Science ®Google Scholar
• Rottner L, Bellmann B, Lin T, et al. Catheter ablation of atrial fibrillation: state of the art and future perspectives. Cardiol Ther. 2020;9(1):45–58. doi:10.1007/s40119-019-00158-2
   PubMed Web of Science ®Google Scholar
• Sato T, Sotomi Y, Hikoso S, et al. Sex differences in the efficacy of pulmonary vein isolation alone vs. extensive catheter ablation in patients with persistent atrial fibrillation. Circ J. 2022;86(8):1207–1216. doi:10.1253/circj.CJ-21-0671
   PubMed Web of Science ®Google Scholar
• Guo F, Li C, Yang L, et al. Impact of left atrial geometric remodeling on late atrial fibrillation recurrence after catheter ablation. J Cardiovasc Med. 2021;22(11):909–916.
   Google Scholar
• Peng Z, Wen-Heng L, Qing Z, et al. Risk factors for late recurrence in patients with nonvalvular atrial fibrillation after radiofrequency catheter ablation. Ann Noninvasive Electrocardiol. 2021;27:e12924. doi:10.1111/anec.12924
   PubMed Web of Science ®Google Scholar
• den Uijl DW, Delgado V, Bertini M, et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart. 2011;97(22):1847–1851. doi:10.1136/hrt.2010.215335
   PubMed Web of Science ®Google Scholar
• Kriatselis C, Unruh T, Kaufmann J, et al. Long-term left atrial remodeling after ablation of persistent atrial fibrillation: 7-year follow-up by cardiovascular magnetic resonance imaging. J Interv Card Electrophysiol. 2020;58(1):21–27. doi:10.1007/s10840-019-00584-1
   PubMed Web of Science ®Google Scholar
• Hussein AA, Saliba WI, Barakat A, et al. Radiofrequency ablation of persistent atrial fibrillation: diagnosis-to-ablation time, markers of pathways of atrial remodeling, and outcomes. Circ Arrhythm Electrophysiol. 2016;9(1):e003669. doi:10.1161/CIRCEP.115.003669
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen M, Zhuo C, Huang Y, Zheng L, Wang Q. The effect of renin-angiotensin system inhibitors on the recurrence of atrial fibrillation after catheter ablation. Int Heart J. 2020;61(6):1174–1182. doi:10.1536/ihj.20-346
   PubMed Web of Science ®Google Scholar
• Zhao Y, Di Biase L, Trivedi C, et al. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm. 2016;13(1):141–149. doi:10.1016/j.hrthm.2015.08.029
   PubMed Web of Science ®Google Scholar
• Sagnard A, Hammache N, Sellal JM, Guenancia C. New Perspective in Atrial Fibrillation. J Clin Med. 2020;9(11):3713. doi:10.3390/jcm9113713
   PubMed Web of Science ®Google Scholar
• Chen G, Chelu MG, Dobrev D, Li N. Cardiomyocyte inflammasome signaling in cardiomyopathies and atrial fibrillation: mechanisms and potential therapeutic implications. Front Physiol. 2018;9:1115. doi:10.3389/fphys.2018.01115
   PubMed Web of Science ®Google Scholar
• Zhang H, Li J, Chen X, et al. Association of systemic inflammation score with atrial fibrillation: a case-control study with propensity score matching. Heart Lung Circ. 2018;27(4):489–496. doi:10.1016/j.hlc.2017.04.007
   PubMed Web of Science ®Google Scholar
• Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243. doi:10.1038/nrcardio.2015.2
   PubMed Web of Science ®Google Scholar
• Oksuz F, Elcik D, Yarlioglues M, et al. The relationship between lymphocyte-to-monocyte ratio and saphenous vein graft patency in patients with coronary artery bypass graft. Biomark Med. 2017;11(10):867–876. doi:10.2217/bmm-2017-0079
   PubMed Web of Science ®Google Scholar
• Quan XQ, Wang RC, Zhang Q, Zhang CT, Sun L. The predictive value of lymphocyte-to-monocyte ratio in the prognosis of acute coronary syndrome patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2020;20(1):338. doi:10.1186/s12872-020-01614-x
   PubMed Web of Science ®Google Scholar
• Yu Y, Wang S, Wang P, et al. Predictive value of lymphocyte-to-monocyte ratio in critically Ill patients with atrial fibrillation: a propensity score matching analysis. J Clin Lab Anal. 2022;36(2):e24217. doi:10.1002/jcla.24217
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Tolstrup JS, Friberg J, Grønbaek M, Jensen G. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol. 2006;98(1):75–81. doi:10.1016/j.amjcard.2006.01.067
   PubMed Web of Science ®Google Scholar
• Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61(2):396–407. doi:10.1016/j.jhep.2014.04.012
   PubMed Web of Science ®Google Scholar
• Zhu S, Zhao H, Zheng M, Peng J. The impact of malnutrition on atrial fibrillation recurrence post ablation. Nutr Metab Cardiovasc Dis. 2021;31(3):834–840. doi:10.1016/j.numecd.2020.12.003
   PubMed Web of Science ®Google Scholar
• Yan Q, Dong J, Ma C. Recurrent pseudo focal atrial tachycardia after ablation of persistent atrial fibrillation. Acta Cardiol. 2013;68(2):213–215. doi:10.1080/AC.68.2.2967283
   PubMed Web of Science ®Google Scholar
• Xiao S, Zhang L, Wu Q, et al. Development and validation of a risk nomogram model for predicting revascularization after percutaneous coronary intervention in patients with acute coronary syndrome. Clin Interv Aging. 2021;16:1541–1553. doi:10.2147/CIA.S325385
   PubMed Web of Science ®Google Scholar